- 全部删除
您的购物车当前为空
CGS 20625 是一种具有口服活性、特异性和高效性的中枢苯二氮卓受体的部分激动剂,具有抗焦虑和抗惊厥活性。CGS 20625 对 [3H]-氟硝西泮与中枢苯二氮卓受体的结合有抑制作用,可用于研究焦虑症和癫痫等神经系统疾病。


为众多的药物研发团队赋能,
让新药发现更简单!
CGS 20625 是一种具有口服活性、特异性和高效性的中枢苯二氮卓受体的部分激动剂,具有抗焦虑和抗惊厥活性。CGS 20625 对 [3H]-氟硝西泮与中枢苯二氮卓受体的结合有抑制作用,可用于研究焦虑症和癫痫等神经系统疾病。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 328 | In stock | |
| 5 mg | ¥ 828 | In stock | |
| 10 mg | ¥ 1,320 | In stock | |
| 25 mg | ¥ 2,280 | In stock | |
| 50 mg | 待询 | In stock |
CGS 20625 相关产品
| 产品描述 | CGS 20625 is an orally active, specific, and potent partial agonist at the central benzodiazepine receptor with anxiolytic and anticonvulsant activity.CGS 20625 inhibits the binding of [3H]-flunitrazepam to the central benzodiazepine receptor and can be used in studies of neurological disorders such as anxiety and epilepsy. |
| 靶点活性 | [3H]-flunitrazepam binding to central benzodiazepine receptors:1.3 nM |
| 分子量 | 309.36 |
| 分子式 | C18H19N3O2 |
| CAS No. | 111205-55-1 |
| Smiles | O=C1C2=CNC3=C(C2=NN1C4=CC=C(OC)C=C4)CCCCC3 |
| 密度 | 1.33 g/cm3 (Predicted) |
| 颜色 | Yellow |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度信息 | Ethanol: <7.73 mg/mL, Sonication is recommended. DMSO: <30.94 mg/mL, Sonication is recommended. |
评论内容